Radiolabelled therapy in the field of neuroendocrine tumors
Abstract
Peptide receptor radiolabelled therapy (PRRT) constitues one of the most promising approach in the field of neuroendocrine tumors. Preliminary studies report a 30 % objective response rate in selected patients based on results of somatostatin receptor scintigraphy. Complexity of clinical research hampered a rapid PRRT development in France. Implementation of randomized study allowing predictors of response to be validated is a...
Paper Details
Title
Radiolabelled therapy in the field of neuroendocrine tumors
Published Date
Oct 1, 2009
Volume
16
Issue
3
Pages
43 - 55
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History